PhloemAid

Biopesticides to Combat Phloem Bacterial Pathogens

Agriculture & Food Technologies
Private

Company Overview

Snapshot

Founded in April 2016, PhloemAid operates with 1–10 employees. The company has raised $650,000 across one funding round from one investor. PhloemAid is a fully owned subsidiary of COPIA Agro and Food Technologies Fund.

Business overview

PhloemAid develops biopesticides to combat phloem bacterial pathogens, which cause significant damage to crops globally. The company's core technology is based on the Frateuria defendens bacterium, effective against diseases like grapevine yellows and citrus greening. PhloemAid's solutions are applicable to a wide range of economically important food crops, including vegetables, fruits, and ornamentals, serving the agriculture and food technologies sector with a focus on plant protection and crop treatment.

Company Intelligence Q&A

What is PhloemAid's primary focus?
PhloemAid focuses on developing biopesticides to combat phloem bacterial pathogens that cause diseases in various crops, leading to significant agricultural damage.
What is the core technology behind PhloemAid's solutions?
PhloemAid's technology utilizes the Frateuria defendens bacterium, which has demonstrated high effectiveness against phloem pathogens in both laboratory and field experiments.
How is PhloemAid's biopesticide applied to plants?
The bacterium developed by PhloemAid can be introduced into plants through both root watering and foliar spraying, allowing for versatile application methods.
Which types of crops can PhloemAid's technology protect?
PhloemAid's technology is effective across numerous crops, including citrus, grapes, carrots, sesame, potatoes, and tomatoes, addressing diseases that impact a broad spectrum of plant species.
What is PhloemAid's relationship with COPIA Agro and Food Technologies Fund?
PhloemAid is a fully owned subsidiary of COPIA Agro and Food Technologies Fund, which also participated as an investor in PhloemAid's seed funding round in April 2016.